Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777751 · ClinicalTrials.gov registry record
Radiation Therapy and Cardiac Enzymes
A clinical trial of Tumor, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00777751: Completed study of Tumor, sponsored by M.D. Anderson Cancer Center.
NCT00777751 is a study of Tumor that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 30 participants, below the 183-participant average among 18 other Tumor trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777751, a study of Tumor, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical research study is to learn if the radiation that you are receiving will result in an increase in certain proteins produced by the heart called cardiac biomarkers.
Conditions Studied
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-10-06 |
| Est. Completion | 2016-11-21 |
What the finished NCT00777751 record still lists
NCT00777751 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 183-participant average among 18 other Tumor trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Tumor appearing as the primary indexed condition, and to 0 interventions.
NCT00777751 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00777751 about?
NCT00777751 is a clinical study titled "Radiation Therapy and Cardiac Enzymes". The goal of this clinical research study is to learn if the radiation that you are receiving will result in an increase in certain proteins produced by the heart called cardiac biomarkers.
What is the current status of trial NCT00777751?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-10-06. Estimated completion is 2016-11-21.
What conditions does trial NCT00777751 study?
This clinical trial studies the following conditions: Tumor.
Who is sponsoring clinical trial NCT00777751?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00777751 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00777751's enrollment target sits among peer trials
30 14th of 18 higher than 5 of 18 other Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Decoupling Immunotherapy Toxicity and Cancer Response
RECRUITING
-
A Study of Live Tumor Fragments of Surgical Resections
RECRUITING
-
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
RECRUITING · Phase 2
-
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
RECRUITING · Phase 2
-
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
RECRUITING · Phase 2
-
Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI